Cat. No. 1192
Biological ActivityPeptide activator of Gi and Go.
(Modifications: Leu-14 = C-terminal amide)
The technical data provided above is for guidance only.
For batch specific data refer to the Certificate of Analysis.
Certificate of Analysis / Safety Data Sheet
Mousli et al (1990) G protein activation: a receptor-independent mode of action for cationic amphiphilic neuropeptides and venom peptides. TiPS 11 358. PMID: 2122563.
Higashijima and Ros (1991) Mapping of the mastoparan-binding site on G proteins. Cross-linking of [125I-Tyr3,Cys11]mastoparan to Go. J.Biol.Chem. 266 12655. PMID: 1905730.
Raynor et al (1991) Membrane interactions of amphiphilic polypeptides mastoparan, melittin, plymixin B and cardiotoxin. J.Biol.Chem. 266 2753. PMID: 1847132.
Longland et al (1999) The mechanism of inhibition of the Ca2+-ATPase by mastoparan. J.Biol.Chem. 274 14799. PMID: 10329678.
If you know of a relevant citation for this product please let us know.
Keywords: Mastoparan, supplier, Activator, Gi, Go, Gi/o, G-Protein, Signaling, Signalling, Heterotrimeric
Find multiple products by catalog number
New Products in this Area
Selective inhibitor of E2 ubiquitin-conjugating enzyme Ubc13-Uev1A
Potent, selective LRRK2 inhibitor
Tocris is the first to launch GSK2578215A, licensed from GlaxoSmithKline, for the study of Parkinson's Disease.